CD40L demethylation in CD4+ T cells from women with rheumatoid arthritis

Clinical Immunology

Volumn 145, Issue 1, 2012, Pages 13-18

  Liao, J ^a   Liang, G ^a   Xie, S ^b   Zhao, H ^b   Zuo, X ^b   Li, F ^a   Chen, J ^a   Zhao, M ^a   Chan, T M ^c   Lu, Q ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CD40L; CD4+ T cells; DNA methylation; Rheumatoid arthritis

Indexed keywords

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD40L GENE; CLINICAL ARTICLE; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CHROMOSOMES, HUMAN, X; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SEX FACTORS; UP-REGULATION;

EID: 84864799962     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.07.006     Document Type: Article

References (27)

1. Weyand C.M. New insights into the pathogenesis of rheumatoid arthritis. Rheumatology 2000, 39:13-18.
2. Dejica D.I., Manea E.M. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis therapeutic perspectives. Roum. Arch. Microbiol. Immunol. 2006, 65:66-74.
3. Quezada S.A., Jarvinen L.Z., Lind E.E., Noelle R.J. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 2004, 22:307-328.
4. Elgueta R., Benson M.J., Vries V.C., Wasiuk A., Guo Y.X., Noelle R.J. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 2009, 229:152-172.
5. Goules A., Tzioufas A.G., Manousakis M.N., Kirou K.A., Crow M.K., Routsias J.G. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J. Autoimmun. 2006, 26:165-171.
6. Lu Q., Wu A., Tesmer L., Ray D., Yousif N., Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 2007, 179:6352-6358.
7. Lleo A., Liao J., Invernizzi P., Zhao M., Bernuzzi F., Ma L., et al. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 2012, 55:153-160.
8. + T-cells from women with systemic sclerosis-a possible explanation for female susceptibility. Arthritis Rheum. 2012 Jan 9, [Epub ahead of print]. 10.1002/art.34376.
9. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31:315-324.
10. Miga A., Masters S., Gonzalez M., Noelle R.J. The role of D40-CD154 interactions in the regulation of cell mediated immunity. Immunol. Invest. 2000, 19:111-114.
11. MacDonald K.P.A., Nishioka Y., Lipsky P.E., Thomas R. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J. Clin. Invest. 1997, 100:2404-2414.
12. Malik N., Greenfield B.W., Kiener P.A. Activation of human monocytes through CD40 induces matrix metalloproteinases. J. Immunol. 1996, 156:3952-3960.
13. Kyburz D., Corr M., Brinson D.C., Von Damm A., Tighe H., Carson D.A. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen. J. Immunol. 1999, 163:3116-3122.
14. Hedrich C.M., Rauen T. Epigenetic patterns in systemic sclerosis and their contribution to attenuated CD70 signaling cascades. Clin. Immunol. 2012, 143:1-3.
15. Trenkmann M., Brock M., Ospelt C., Gay S. Epigenetics in rheumatoid arthritis. Clin. Rev. Allergy Immunol. 2010, 39:10-19.
16. Rodrigues H.M., Jungel A., Gay R.E., Gay S. Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis. Mol. Immunol. 2009, 47:12-18.
17. Ospelt C., Reedquist K.A., Gay S., Tak P.P. Inflammatory memories: is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis?. Autoimmun. Rev. 2011, 10:519-524.
18. Fu L.H., Ma C.L., Cong B., Li S.J., Chen H.Y., Zhang J.G. Hypomethylation of proximal CpG motif of interleukin-10 promoter regulates its expression in human rheumatoid arthritis. Acta Pharmacol. Sin. 2011, 32:1373-1380.
19. Nile C.J., Read R.C., Akil M., Duff G.W., Wilson A.G. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum. 2008, 58:2686-2693.
20. + T cells with epigenetic immune lineage analysis. J. Immunol. 2011, 186:92-102.
21. Takami N., Osawa K., Miura Y., Komai K., et al. Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheum. 2006, 54:779-787.
22. Libert C., Dejager L., Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat. Rev. Immunol. 2010, 10:594-604.
23. Basu R., Zhang L.F. X chromosome inactivation: a silence that needs to be broken. Genesis 2011, 49:821-834.
24. Chitnis S., et al. The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res. 2000, 2:399-406.
25. Pham L.V., Tamayo A.T., Yoshimura L.C., Lin-Lee Y.C., Ford R.J. Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 2005, 106:3940-3947.
26. Schubert L.A., King G., Cron R.Q., Lewis D.B., Aruffo A., Hollenbaugh D. The human gp39 promoter. Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation. J. Biol. Chem. 1995, 270:29624-29627.
27. Pham L.V., Tamayo A.T., Li C., Bueso-Ramos C., Ford R.J. An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas. Blood 2010, 116:3899-3906.